Dr. Marty L Allison, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Mac Lane, Avera Medical Group Pierre, Pierre, SD 57501 Phone: 605-945-5246 Fax: 605-945-5295 |
Dr. Bretta M Olson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Mac Ln, Pierre, SD 57501 Phone: 605-224-5901 Fax: 605-945-5295 |
News Archive
A recent study has found that a childhood behavioral intervention to lower dietary intake of total fat and saturated fat and increase consumption of foods that are good sources of dietary fiber resulted in significantly lower fasting plasma glucose levels and lower systolic blood pressure when study participants were re-evaluated in young adulthood.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
The Immune Deficiency Foundation commends the states of Maine and Rhode Island for adding Severe Combined Immune Deficiency to their states' newborn screening panels, effective August 1, 2014. These states join 21 other states currently screening newborns for SCID, ensuring over two thirds of all babies in the U.S. are now being screened.
A seven-state snapshot of enrollment by the Kaiser Family Foundation indicates that the overhaul has not significantly boosted competition. (Kaiser Health News is an editorially independent part of the Foundation.)
› Verified 3 days ago